SCHEMBL16601576

SCHEMBL16601576

Cc1cnc2c(c1)OC(F)(F)C(=O)N2C

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16972895 0.84 GABRG2 (0.34) GABRG2GABRB3GABRA5
SCHEMBL15743906 0.83 LMNA (0.42)
SCHEMBL13340901 0.82 GABRG2 (0.33) GABRG2GABRB3GABRA5
SCHEMBL15786403 0.81 MARK3 (0.31)
SCHEMBL16601589 0.72 GABRG2 (0.42) GABRG2GABRB3GABRA5
SCHEMBL13367734 0.71 CCNC (0.35)
SCHEMBL16601593 0.69 BRD4 (0.37)
SCHEMBL46323 0.69 GABRA5 (0.46) GABRG2GABRB3GABRA5
SCHEMBL46311 0.68 MARK3 (0.36)
SCHEMBL16601578 0.68 MAPT (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 US disclosed